Opiate reward: Sites and substrates

Neuroscience and Biobehavioral Reviews

Volumn 13, Issue 2-3, 1989, Pages 129-133

  Wise, Roy A ^a  

^a and Applied Physiology   (Canada)

Author keywords

Aversion; Opioids; Reward

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; BACLOFEN; DYNORPHIN A; MORPHINE; MUSAMOL; NEUROLEPTIC AGENT; OPIATE; OPIATE PEPTIDE; OPIATE RECEPTOR; PIMOZIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AVERSIVE BEHAVIOR; DOPAMINERGIC SYSTEM; HYPOTHALAMUS; NONHUMAN; NUCLEUS ACCUMBENS; PSYCHOLOGICAL ASPECT; REWARD; SHORT SURVEY; VENTRAL TEGMENTUM;

ANIMAL; BRAIN; DOPAMINE; DYNORPHINS; HYPOTHALAMUS; NARCOTICS; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY; REWARD;

EID: 0024456225     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(89)80021-1     Document Type: Article

References (81)

1. Opposite motivational effects of endogenous opioids in brain and periphery
2. Peripheral receptors mediate the aversive conditioning effects of morphine in the rat
3. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats
4. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats
5. Intracranial self-stimulation as a technique to study the reward properties of drugs of abuse
6. Intracranial self-administration of morphine into the ventral tegmental area of rats
7. Heroin reward is dependent on a dopaminergic substrate
8. Localization of the reward-relevant opiate receptors
9. Dissociation of the rewarding and physical dependence-producing properties of morphine
10. Anatomically distinct opiate receptor fields mediate reward and physical dependence
11. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement
12. Opiate rewarding action: Independence of the cells of the lateral hypothalamus
13. Akinesia after locally applied morphine near the nucleus raphe pontis of the rat
14. The effect of microinjections of amphetamine into the neostriatum and the nucleus accumbens on self-stimulation behavior
15. Separation of inhibiting and stimulating effects of morphine on self-stimulation behavior by intracerebral microinjections
16. Effects of nucleus accumbens amphetamine on lateral hypothalamic brain stimulation reward
17. Electrical self-stimulation of dentate gyrus granule cells
18. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
19. Drugs of abuse preferentially stimulate dopamine release in the mesolimbic system of freely moving rats
20. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
21. The role of the dopaminergic projections in MFB self-stimulation
22. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation
23. Pimozide and amphetamine have opposing effects on the reward summation function
24. Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: A variable dose paradigm
25. Self-administration of methionine enkephalin into the nucleus accumbens
26. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons — 2. Action potential generating mechanisms and morphological correlates
27. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording
28. Effects of acute thioridazine, metoclopramide and SCH 23390 on the basal activity of A9 and A10 dopamine cells
29. Ascending endorphin inhibition of distress vocalization
30. Self-injection of amphetamine directly into the brain
31. Circling from intracranial morphine applied to the ventral tegmental area in rats
32. Contralateral circling induced by tegmental morphine: Anatomical localization, pharmacological specificity, and phenomenology
33. Comparison of morphine-induced effects on dopamine and non-dopamine neurons in the rat ventral tegmental area
34. Dynorphin A [1–17]place preference in rats: Opioid-specific and dopaminergic
35. Opposite effects of ventral tegmental and periaqueductal gray morphine injections on lateral hypothalamic stimulation-induced feeding
36. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward
37. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat
38. Enkephalin action on the mesolimbic system: A dopamine-dependent and a dopamine-independent increase in locomotor activity
39. Dynorphin immunocytochemistry in the rat central nervous system
40. Neurochemical substrates for opiate reinforcement
41. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning
42. Electrophysiological evidence for excitation of rat ventral tegmental area dopaminergic neurons by morphine
43. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
44. Suppression of operant responding in the rat by dopamine D1 receptor blockade with SCH 23390
45. Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390
46. Heroin self-administration in the rat suppressed by SCH 23390
47. Hypothalamic substrate for the positive reinforcing properties of morphine in the rat
48. Reinforcing effects of morphine in the nucleus accumbens
49. Self-administration of D-ala2-metenkephalinamide at hypothalamic self-stimulation sites
50. The effects of low doses of morphine on the activity of dopamine containing cells and on behavior
51. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats
52. Reinforcing effects of morphine microinjection into the ventral tegmental area
53. 2 enkephalinamide into the ventral tegmental area
54. Depolarization inactivation of A9 or A10 dopamine neurons blocks bar-pressing for electrical stimulation of the medial forebrain bundle
55. Opioid-neuroleptic interaction in brain-stem self-stimulation
56. Behavioral evidence for midbrain dopamine depolarization inactivation
57. Intracranial chemical injection and behavior: A critical review
58. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of u- and k-opioid agonists
59. Haloperidol effects on morphine self-administration: Testing for pharmacological modification of the primary reinforcement mechanism
60. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
61. Self-administration in CA3 hippocampal field in the rat
62. Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens
63. Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates
64. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: Evidence for a pre-synaptic locus
65. Body temperature responses to microinjections of morphine in brain sites containing opiate receptors
66. Involvement of neurohypophyseal peptides in drug-mediated adaptive responses
67. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference
68. Physical dependence on opiate-like peptides
69. Nucleus accumbens opioids facilitate brain stimulation reward
70. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist
71. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat
72. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens
73. Action of drugs of abuse in brain reward systems
74. Brain reward circuitry: Four circuit elements “wired” in apparent series
75. Opiate receptor subtypes associated with the brain mechanisms of feeding and reward
76. SCH 23390 shifts the self-stimulation rate-frequency function of 0.6 log units
77. Brain dopamine and reward
78. Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function
79. Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques
80. The cells and axons mediating medial forebrain bundle reward
81. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens